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Abstract
Bacteria have evolved intricate secretion machineries for the successful
delivery of large molecules across their cell envelopes. Such specialized
secretion systems allow a variety of bacteria to thrive in specific host environ-
ments. In mycobacteria, type VII secretion systems (T7SSs) are dedicated
protein transport machineries that fulfill diverse and crucial roles, ranging
from metabolite uptake to immune evasion and subversion to conjugation.
Since the discovery of mycobacterial T7SSs about 15 y ago, genetic, struc-
tural, and functional studies have provided insight into the roles and func-
tioning of these secretion machineries.Here, we focus on recent advances in
the elucidation of the structure and mechanism of mycobacterial T7SSs in
protein secretion. As many of these systems are essential for mycobacterial
growth or virulence, they provide opportunities for the development of
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1. INTRODUCTION
Mycobacterium tuberculosis was the cause of over 10 million new cases of tuberculosis and 1.5 mil-
lion deaths in 2018 alone (116). Mycobacteria use type VII secretion systems (T7SSs), also called
ESX systems, to transport a diverse repertoire of proteins across their distinctive diderm cell enve-
lope. Since the discovery of mycobacterial T7SSs, approximately 15 y ago (98), evidence has been
mounting as to the central roles of these protein transport machineries for the successful establish-
ment of infection, especially of the clinically relevant species, and also for the fitness of mycobacte-
ria (1, 15, 41, 50, 68, 86).With up to five different mycobacterial T7SSs, named ESX-1 to ESX-5,
their importance is further emphasized by the lack of the ESX-1 system as the decisive factor in
the attenuation of the live attenuated vaccine strainMycobacterium bovis BCG (81, 93). T7SSs are
prime candidates for targeted drug discovery, given their overall importance in the life cycle of
pathogenic mycobacteria (25, 85). As such, knowledge of the exact structure and function of these
systems and their components is crucial in identifying new ways to combat mycobacterial diseases.
T7SSs are not specific for mycobacteria but are well conserved in a wide range of other
Actinobacteria, including species with a monoderm cell envelope (55). The functionality of T7SSs
in other Actinobacteria has only been studied in several Streptomyces species (3, 43), but their
role in protein secretion in these organisms is far from clear. In addition, related T7SSs are
functional in several Firmicutes, such as Staphylococcus aureus and Bacillus subtilis, although they
share only a limited number of the mycobacterial T7SS components and thereby will have a
distinct architecture (15). The homologous system in S. aureus, named Ess, has been shown to be
required for virulence in different infection models and to be involved in toxin-mediated bacterial
competition (20).While the role of the B. subtilis system, called the YukE/Yue system, is less clear,
specific RNase toxins are predicted to be secreted by this system (52). Predicted T7SS secreted


























































































toxins are actually widespread in Firmicutes, indicating a dedicated role of T7SSs in interbacterial
antagonism in this phylum (115). In this review, we focus on mycobacterial T7SSs and provide
an overview of new findings on their structure and function.
1.1. Build-Up of the Mycobacterial Cell Envelope
The complex cell envelopes of bacteria are pivotal components for their existence in a wide range
of environments. For instance, pathogenic mycobacteria strictly depend on their unique cell en-
velope to withstand conditions faced during their intracellular infection cycle. Small alterations to
this layer will generally lead to attenuation. The mycobacterial cell envelope is complex and com-
posed of a cytoplasmic membrane, a cell wall with a specific outer membrane (OM), also known
as the mycomembrane, and an outermost capsule-like layer (29, 36). The mycobacterial cell en-
velope is highly hydrophobic, with up to 40% of its dry weight attributable to lipids, as compared
to the 20% lipid content found in gram-negative bacteria (16, 28).
While the mycobacterial cytoplasmic membrane is largely similar to that of gram-positive and
gram-negative microorganisms (28), it does contain specific lipids, such as phosphatidylinositol
mannosides, lipomannans, and lipoarabinomannans (36). The mycobacterial cell wall is more spe-
cific, as it consists of a peptidoglycan layer that is covalently linked to an additional polymer of
arabinose and galactose, called the arabinogalactan layer. In addition, this structure is even more
extended, as linked to the arabinogalactan layer are long-chain fatty acids (C60 to C90), called my-
colic acids, that make up part of the inner leaflet of the mycobacterial outer membrane. The outer
leaflet of this second membrane contains free mycolic acids, of which some are linked to trehalose
residues to make trehalose monomycolate or trehalose dimycolate, and other specific lipids. The
overall low permeability of the mycobacterial cell envelope provides intrinsic resistance to many
antibiotics and other antimicrobial (host) factors.
The outermost capsular layer can be observed by cryo–electron microscopy (cryo-EM) as a
labile structure that is sensitive to the presence of detergents, which are in fact regularly added to
mycobacterial growth media as anticlumping agents (87). This outer layer, which is composed of
proteins, glycan-like polysaccharides, and small amounts of lipids, has been implicated as impor-
tant for the pathogenesis of M. tuberculosis (57). Its molecular composition is believed to be dif-
ferent between pathogenic and nonpathogenic species (29, 63, 73). Recent data have outlined an
important role for the ESX-5 system and one of its secreted substrates, PPE10, in maintaining the
integrity of the capsular layer in the fish pathogen and model speciesMycobacterium marinum (9).
Mycobacteria use a set of secretion systems to transport proteins across their distinctive di-
derm cell envelope. The conserved Sec and Tat translocation systems, which exist in all bacteria,
mediate protein transport over the inner membrane, as recently reviewed in Reference 110. Sub-
strates of these two pathways contain a characteristic N-terminal signal peptide that is cleaved
off upon transport. In addition to this, mycobacteria possess the SecA2 pathway, which exports in
concert with the canonical Sec translocon a small subset of proteins (110).While some of the Sec
and Tat substrates remain in the putative periplasmic space between the two membranes, other
proteins are fully secreted into the extracellular environment by currently unknown secondary
mechanisms. For T7SSs, localization of substrates in the periplasm has not been observed so far,
indicating that this pathway is dedicated for the transport of proteins across the complete envelope
of mycobacteria.
1.2. Roles of ESX Systems in Virulence, Bacterial Physiology, and Conjugation
The initial characterization of T7SSs focused on their critical roles in virulence, such as phagoso-
mal escape and immune modulation. However, in more recent years it has become clear that ESX


























































































systems and their substrates play more diverse roles, including horizontal gene transfer, nutrient
and metabolite uptake, and cell physiology (50, 68, 110). While the ESX-2 system has not been
characterized, the roles of the other four systems have been studied to various degrees.
ESX-1 is the first discovered and one of the best described mycobacterial T7SSs. It plays
an important role in the macrophage infection cycle of pathogenic species. M. tuberculosis and
M. marinum have been shown to be able to rupture the phagosomal membrane and thereby
translocate to the cytosol (44, 93). In the cytosol they replicate and induce necrosis-like cell death,
resulting in bacterial spread to other macrophages (50). In the absence of an active ESX-1 system,
mycobacteria remain in the phagosomal compartment (53, 93). The ability to lyse erythrocytes
is also lost in esx-1 mutants (44, 58). While membrane-lysing activity has been observed for the
major ESX-1 substrate, EsxA (34, 58, 94), the role of this substrate in phagosomal rupture has
recently been challenged (27; see below).
In nonpathogenicMycobacterium smegmatis, ESX-1 seems to have a very different role, as in this
species the system has been shown to be involved, together with the more archaic ESX-4 system,
in a special form of horizontal gene transfer called distributive conjugal transfer (DCT) (48). This
process is unidirectional and allows for the transfer of large fragments of chromosomal DNA (49).
Interestingly, the recipient and donor strains have different genetic requirements for DCT to take
place. While the recipient strain requires both an ESX-1 system and an ESX-4 system for DNA
uptake, for the donor strain crucial mutations in the ESX-1 system result in hyperconjugation,
and ESX-4 is dispensable for DCT (48). In addition, the ESX-4 transcription regulator SigM is
upregulated in the recipient strain upon contact with the donor cell, suggesting that ESX-4 is
induced upon cell-cell contact (24). Another ESX system plays a role in a more classical form of
conjugation, namely, the ESX-P1 system encoded by the pRAW plasmid in M. marinum (105).
Conjugation of pRAW is in fact dependent on two separate plasmid-encoded gene clusters, one
coding for ESX-P1 and the second encoding for a type IV–like secretion system.Type IV secretion
systems are required and sufficient for plasmid conjugation in other bacteria (23). More pRAW-
like plasmids have been identified in different mycobacterial species with the same gene clusters,
leading to the hypothesis that these plasmids could also be conjugative and important for the
evolution and distribution of esx gene clusters (71).
ESX-4 is considered to be themost archaic ESX system, but its function is still ill characterized.
Inmost species it is lacking a number of genes that are present in the other ESX systems, i.e., genes
encoding for PE and PPE substrates and the conserved system components EspG and EccE (12,
26; see below). Besides its role in DCT inM. smegmatis, ESX-4 has been described to be required
for full virulence inMycobacterium abscessus (62). More specifically, a functional ESX-4 system was
shown to be required for phagosomal rupture and bacterial escape to the cytosol (62). Of note
is that in M. abscessus, in contrast to the case of most ESX-4 systems, a copy of EccE4 is present.
Furthermore, M. abscessus lacks an ESX-1 system, suggesting that ESX-4 takes over the role of
ESX-1 in this species.
While ESX-1, ESX-2, and ESX-4 are dispensable for growth of M. tuberculosis, both the
ESX-3 and the ESX-5 systems are essential for viability, probably due to their role in the uptake of
metabolites and nutrients, respectively (8, 88). In addition, specific ESX-3 and ESX-5 substrates
have been implicated to play a role in immune modulation (6, 103). The ESX-3 system is up-
regulated under low levels of iron (67, 83) and is involved in the uptake of iron (92), and in the
case ofM. tuberculosis also of zinc (89). Its role in iron uptake is further supported by the fact that
addition of high levels of hemin in the growth medium allows for mutations in the esx-3 locus of
M. tuberculosis (89).
ESX-5 is the most recently evolved T7SS (71) and is only present in slow-growing mycobac-
teria, which include most pathogenic species, such as M. tuberculosis, M. leprae, M. ulcerans, and


























































































M. marinum (46). The role of ESX-5 in nutrient uptake is supported by the observation that
this system is involved in uptake and utilization of fatty acids in M. marinum (8) and that in M.
tuberculosis ESX-5 is upregulated under low phosphate conditions by the Pst-SenX3-RegX3 sys-
tem (39). In addition, the essentiality of ESX-5 can be alleviated in M. marinum by increasing
the OM permeability, either by mutations that block synthesis of phthiocerol dimycocerosates
and phenolic glycolipids or by heterologous expression of the MspA porin, which is exclusively
found in fast-growingmycobacterial species (8, 99).This suggests that ESX-5 or ESX-5 substrates
play a role in nutrient transfer across the mycobacterial OM. Recently, it has been shown that, in
M. tuberculosis, specific PE/PPEs might indeed act as selective channels to take up nutrients across
the impermeable mycomembrane (61, 114).
2. T7SS SUBSTRATES
2.1. Esx Substrates
T7SS substrates are among the most abundantly secreted proteins in mycobacteria. An unusual
feature of these proteins is that many of them are secreted as (partially) folded heterodimers. The
first group of substrates, called Esx proteins, belongs to the family of WxG100 proteins, which
are characterized by a length of approximately 100 amino acids and a conserved WxG motif in
between two α helices. One partner protein of Esx heterodimers has a C-terminal conserved se-
quence YxxxD/E, which is required for secretion (78). In mycobacteria, the two genes that encode
for these heterodimers are always paired in an operon. In contrast, for the T7SS-like systems of
certain Firmicutes species, the Esx proteins are produced from monocistronic transcripts and are
secreted as homodimers (10, 90, 102). Each of the five mycobacterial T7SS loci contains a pair of
esx genes. Furthermore, additional esx gene pairs that are highly homologous to the loci-associated
genes are scattered throughout the mycobacterial genome (12, 26).
The first-discovered and best-studied Esx heterodimer, the EsxB/EsxA proteins (also called
CFP10/ESAT-6), are secreted via the ESX-1 system.The two proteins interact by their helix-turn-
helix structures in an antiparallel manner, forming a four-helix bundle,which is a conserved feature
for all T7SS substrates (4, 56) (Figure 1a). The structure of the EsxB/EsxA complex also reveals
that the N- and C-terminal tails of both proteins are flexible (Figure 1a). This has important
implications, as the C terminus of EsxB, which also contains the YxxxD/E secretion signal, is
recognized by the ESX-1 secretion machinery (22, 84).This YxxxD/Emotif is structurally in close
proximity to the WxG motif of the partner protein EsxA, likely forming a composite secretion
signal (82).
EsxA has been shown to have pore-forming abilities after dissociation from EsxB postsecre-
tion, suggesting this substrate is responsible for phagosomal rupture upon macrophage infection
(93, 106). As EsxB does not show any membrane-lysing competence, this protein is hypothesized
to be a chaperone, keeping EsxA in a translocation-competent state (34, 94). The role of EsxA
in phagosomal rupture, however, is still debatable, as newer studies assigned the pore-forming
activities to the detergents present in the protein preparations (27).
2.2. PE/PPE Substrates
The largest group of T7SS substrates is the highly polymorphic PE and PPE proteins that, with
169 pe and ppe genes, cover ∼10% of the coding capacity ofM. tuberculosis (26). Both the PE and
PPE protein families are named after their conserved proline (P) and glutamic acid (E) motifs,
present at their N termini. esx clusters, except for esx-4, contain pe and ppe genes, but most PE and
PPE substrates are not encoded by esx loci (12, 26, 46). PE and PPE proteins contain conserved























































































































Structures of type VII secretion system substrates. (a) Ribbon representations of the NMR structure of EsxA/EsxB (PDB 1WA8) with
the flexibility of the N and C termini indicated by motion lines, (b) crystal structures of PE25/PPE41 (PDB 2G38), (c) PE25/PPE41/
EspG5 (PDB 4KXR), and (d) EspB (PDB: 4WJI), and (e) superposition of EspB with PE25/PPE41 (PDB 4WJI and 2G38). The
YxxxD/E secretion signal motif and WxG motif are shown in red. Dotted lines represent missing structural features. ( f ) Side and top
views of a negative-stain model of an EspB multimer (EMD 6120) with a heptameric EspB model (PDB 3J83) fit into the EM density.
The hydrophobic rim proposed to be able to penetrate membranes is depicted in yellow. N and C denote the N termini and C termini.
Abbreviations: EM, electron microscopy; EMD, Electron Microscopy Data; NMR, nuclear magnetic resonance; PDB, Protein Data
Bank.
N-terminal so-called PE and PPE domains of ∼110 and 180 amino acids, respectively (6, 46),
while their C termini can be highly variable in sequence and size (46).
The conserved PE and PPE domains that have been examined show a characteristic helix-
turn-helix structure, akin to the Esx substrates (100) (Figure 1b). For PE proteins, these two α
helices almost completely cover the 110–amino acid PE domain,which also contains the conserved
YxxxD/E secretion signal at the C terminus (30, 84, 96).The slightly longer PPE domain contains,
besides a helix-turn-helix structure with the conserved WxG motif in the turn, three additional α
helices (Figure 1b). This extended domain, not present in PE and Esx proteins, binds the EspG
chaperone (see below).


























































































Several pe genes are paired with a ppe gene in an operon, and these paired genes produce
PE/PPE heterodimers (6, 46, 86). Dimerization is mediated by the two helices of the PE domain
together with the helix-turn-helix structure of the PPE domain, forming an antiparallel four-helix
bundle, similar to Esx heterodimers. Also in these heterodimers, the YxxxD/E motif in the C ter-
minus of the PE protein is placed in proximity to the conserved WxG motif of the PPE protein
(38, 59, 100).
The highly variable C-terminal domains of PE and PPE proteins are much less characterized,
as only a few PE and PPE proteins have (predicted) functional domains in this region (19, 35, 103).
Nevertheless, several conserved motifs can be distinguished in these C-terminal domains, which
have been used to subclassify pe and ppe genes. The major subgroup of the PE protein family
is the PE_PGRS proteins, named after the polymorphic GC-rich repetitive sequence motifs in
their genes. While some studies show that PE_PGRS proteins are required for virulence (14,
41), another study indicated a role in virulence attenuation (7). PPE proteins can be subdivided
into three distinct subclasses, i.e., the PPE-PPW proteins that contain a PxxPxxW motif close
to their C terminus, the PPE-SVP proteins that contain an SVP amino acid sequence at their
C terminus, and the most recently evolved group of PPE-MPTR proteins, named after the
presence of major polymorphic tandem repeat sequences that vary around a NxGxGNxG motif
(6, 46).
As the genetic analysis of PE/PPE substrates is complicated by their large number of repeats
and high sequence identity due to gene duplications, a clear function has not been assigned for
most of them. Additionally, detection by mass spectrometry is hindered by the low number of
trypsin digestion sites.
2.3. Esp Substrates
While each ESX system secretes its own set of Esx, PE, and PPE proteins, the final group of sub-
strates, i.e., the Esp (ESX secretion associated protein) proteins, are specific for the ESX-1 system
(21, 70, 77). Structural information is only available for EspB, which is secreted as a monomer and
cleaved by the conserved component MycP1 upon export (72) (Figure 1d; see below). Although
monomeric, the N-terminal part of this protein shows a structure that is highly similar to that
of the PE/PPE heterodimer (96) (Figure 1e). Interestingly, this N-terminal domain of EspB has
been shown to multimerize into doughnut-shaped heptamers, hypothesized to be able to insert
into host cell membranes via a hydrophobic rim (60, 96) (Figure 1f ). A number of Esp proteins,
especially EspA, EspC, and EspD, which are encoded by the same operon, have been shown to be
involved in ESX-1 functioning, as deletion of the corresponding genes results in a general ESX-1
secretion defect (42, 66). As the espACD operon has been found only in slow-growing and thereby
pathogenic mycobacteria and it is transcriptionally regulated by multiple regulatory systems (50),
it has been suggested to be involved in virulence. Three Esp proteins that are encoded by the
esx-1 locus, i.e., EspE, EspF, and EspH, are homologous to EspA, EspC, and EspD, respectively
(77). EspC and EspF have, similar to Esx proteins, a size of ∼100 amino acids and contain the
conserved YxxxD/E motif at their C terminus. In addition, these proteins interact with EspA
and EspE, respectively, suggesting these Esp proteins are also secreted as heterodimers (64, 77).
EspH, which is not secreted, is required for the secretion of the EspE/EspF pair and interacts
with EspE in the cytosol, suggesting this protein acts as a specific chaperone for the secreted
Esp pair (77). As two other Esp proteins, i.e., EspD and EspL, show (structural) homology to
EspH, these proteins might constitute a group of specific chaperones for the Esp substrate family
(75).


























































































3. T7SS CYTOSOLIC COMPONENTS
3.1. EspG and Other Specific Chaperones
EspG proteins are conservedT7SS chaperones that are exclusively located in the cytosol.They are
present in all mycobacterial esx loci that encode PE/PPE substrates (75). Due to their shared low
identity, they were originally not considered an Ecc (ESX conserved component) and therefore
mistakenly named Esp (12). EspG chaperones specifically interact with their cognate PE/PPE
heterodimers in the cytosol (31), and this interaction is essential for secretion.For instance,EspG5,
i.e., EspG of the ESX-5 system, is important for the secretion of several ESX-5 substrates (2),
whereas the absence of EspG1 results in a defect of the ESX-1 substrate PPE68 (14).
Although EspG components from different esx loci show relatively little sequence conser-
vation, their overall structure is highly similar, with a quasi-twofold symmetry, where each half
contains five β strands and four helices (38, 59, 104). Heterotrimeric EspG5-PE25-PPE41 crystal
structures reveal that EspG5 interacts at the helical tip of the PPE protein through multiple
hydrophobic interactions, hydrogen bonds, and salt bridges (31, 38, 59) (Figure 1c). The tip
structure, consisting of the loop between helices four and five of the PPE protein, is inserted
in a hydrophobic groove of the EspG chaperone, which protects the PE/PPE dimer from
self-aggregation (38, 59) (Figure 1c). The tip region is well conserved among the ESX-1, ESX-3,
and ESX-5 secreted PPE proteins, and so far, no specific amino acids have been found to define
the specificity for EspG binding (38, 59). Importantly, the EspG-binding domain is involved in
determining system specificity, as exchanging this domain between PPE proteins of different
ESX systems, i.e., ESX-1 and ESX-5, leads to their rerouting via the new system inM. marinum
(76). As discussed above, similar specific chaperones might be required for the secretion of Esp
proteins, namely EspH and its homologs.
As also already mentioned, from the observation that at least several substrates are secreted
as heterodimers, it has been suggested that one partner protein of these heterodimers might act
as a (second) chaperone of the other partner protein (1). However, it is highly unusual that these
potential chaperones are cosecreted with their substrates, suggesting that they might also have a
role during translocation over the mycobacterial cell envelope.
3.2. EccA
EccA is a T7SS cytosolic conserved component that belongs to the family of AAA+ (ATPases asso-
ciated with diverse cellular activities) proteins and potentially has chaperone-like activity. Similar
to the case of pe, ppe, and espG genes, eccA is present in all esx loci, except esx-4 (12, 26). EccA is
composed of two structural domains, the C-terminal AAA+ ATPase domain and an N-terminal
domain that contains six tandem tetratrico-peptide-repeat (TPR) motifs, known to be involved in
protein-protein interactions (45, 65, 113). Only the structure of the TPR domain has been solved,
showing 12 antiparallel helices arranged into the six TPR motifs (113). In vitro expression of only
the ATPase domain shows more robust activity compared to the full-length protein, suggesting
that the N terminus might play a regulatory role. Although not solved structurally, the C-terminal
ATPase domain can be modeled based on available structures of other AAA+ proteins (65). These
models show that the ATPase domain drives oligomerization into hexamers, a general feature of
AAA+ proteins (65).
Although EccA is a conserved component, its role in secretion remains unclear. While several
reports have documented the requirement of EccA1 and EccA5 for secretion of ESX-1 and ESX-5
substrates, respectively, other studies have shown that they are dispensable for secretion (75). This
variation can be explained by a more recent observation where the importance of EccA1 in the
secretion of ESX-1 substrates inM. marinum varied between different growth media (77).


























































































As EccA homologs are present only in systems that encode for PE/PPE substrates, and an
AAA+ ATPase is involved in the disassembly of the type VI secretion apparatus (13), EccA has
been proposed to have a role in the dissociation of the EspG chaperone from the PE/PPE substrate
heterodimers upon targeting to the membrane complex for secretion (38). However, evidence for
such a role is still lacking.
4. T7SS MEMBRANE COMPLEX
4.1. Membrane Components
The mycobacterial ESX systems contain a set of five conserved membrane proteins called EccB,
EccC, EccD, EccE, and MycP. All systems code for these five membrane components, besides
ESX-4, which usually does not have a copy of EccE, the exception being M. abscessus. Structures
of several soluble domains of thesemembrane components have been solved byX-ray crystallogra-
phy (84, 95, 111, 112, 117) (Figure 2a–d). In addition, structures of ESX-5 and ESX-3 complexes,
composed of the four Ecc components, have recently been solved by negative stain and cryo-EM

































Membrane components of mycobacterial type VII secretion systems. Crystal structures of (a) soluble domain of EccB1 from
Mycobacterium tuberculosis (PDB 4KK7), (b) the three NBDs of EccC from Thermomonospora curvata (PDB 4NH0), with linker 2
connecting the first and second NBD in yellow, (c) the third NBD of EccC from T. curvata (light blue) in complex with a peptide
mimicking the C terminus of EsxB (dark blue; PDB 4N1A), and (d) dimeric soluble domain of EccD1 fromM. tuberculosis (PDB 4KV2).
(e) Front and top views of a cryo–electron microscopy structure of the dimeric ESX-3 membrane complex fromM. smegmatis (PDB
6UMM). N and C denote the N termini and C termini. Abbreviations: NBD, nucleotide-binding domain; PDB, Protein Data Bank.




































































































Hexameric view of the membrane complex. (a) Side and top views of a negative-stain electron microscopy
structure of the ESX-5 membrane complex fromMycobacterium xenopi (EMD 3596). (b) Side and top views of
a hexameric model of the ESX-3 membrane complex based on the dimeric structure from Figure 2e (PDB
6UMM), dimeric EccB (PDB 6SGY), and a structural model of EccC3 generated with Phyre2 using the
structure of EccC from Thermomonospora curvata (PDB 4NH0) as a template. The flexibility of the soluble
domains of the EccB3 and EccC3 subunits is indicated by motion lines. Abbreviations: EMD, Electron
Microscopy Data; PDB, Protein Data Bank.
EccB is a single-pass transmembrane protein that mainly localizes to the periplasm with an
elongated domain in the shape of a distorted propeller showing a quasi-twofold symmetry (111,
117) (Figure 2a). The structure contains a hydrophobic core domain that is stabilized by a disul-
fide bridge between the central β strands and is flanked by two repeat domains on each side (111).
Although it has no obvious structure similarity, it shows weak homology to the gram-positive


























































































phage lysin protein PlycB, suggesting it might be able to bind to the cell wall (111), which, given
its localization, seems likely. The observation that EccB would have ATPase activity is rather un-
usual, as the compartment where the main portion of this protein is located, the periplasm, is
devoid of ATP (117). While predominantly periplasmic, the high-resolution cryo-EM structure
of an ESX-3 membrane complex shows that the small N terminus of EccB3 reaches into the cyto-
plasm,where it interacts with EccC3 (40, 79). This suggests that potential conformational changes
that take place upon substrate binding and/or nucleotide hydrolysis by EccC (see below) could in-
duce conformational changes of the periplasmic domain of EccB (11, 40; see below).
EccD is, with 11 transmembrane domains, the most hydrophobic membrane component. The
∼110–amino acid structure of the soluble N-terminal domain of EccD shows a ubiquitin-like fold
and is dimeric in solution (111) (Figure 2d). In the context of the membrane complex, EccD forms
crucial interactions with both EccC and EccE, revealing why previous characterizations of eccD5
knockouts inM. tuberculosis showed a strong negative effect on the functionality and assembly of
the ESX-5 membrane complex (54).
EccE has two transmembrane domains and a C-terminal cytosolic domain that shows weak
structural homology to glycosyl transferase proteins, although it lacks binding pockets or catalytic
sites (11, 79). EccE is localized at the exterior of the membrane complex (11, 40, 79).
The EccC ATPase contains two transmembrane domains at its N terminus and is, together
with the Esx dimers, the only protein that is conserved in the related T7SSs in Firmicutes and
therefore a central component of T7SSs (12, 74). Protein predictions and subsequent structural
studies show that the protein has three consecutive FtsK/SpoIIIE-like nucleotide-binding do-
mains (NBDs) (12, 84) (Figure 2b).Members of the FtsK/SpoIIIE ATPase family form hexamers,
which is generally the state in which they show ATP hydrolysis capacities (5, 37), and in certain
cases activity/hexamerization is regulated by substrates (69). Of the three domains, the ATPase
activity of only the first one is critical for system functionality (8, 84). The ATPase activities of the
twomost C-terminal domains are only required for optimal protein secretion and probably serve a
regulatory role within T7SSs (8, 84). Critical for EccC ATPase activity seems to be an uncoupling
event where the detachment of the so-called linker 2 domain from the first NBD is required for
NBD1 activation (84). From structural data on the ESX-3 complex, it appears that the previously
characterized DUF domain, which links the transmembrane domains and the three NBDs (84),
actually exhibits an NTPase-like fold and might be an additional ATPase domain (40). This DUF
domain interacts with the cytoplasmic domain of EccD and the N-terminal tail of EccB in the
membrane complex (40, 79). An interesting feature of the EccC ATPase is its inherent flexibility
(11, 40, 79, 84). This has been observed both for the isolated soluble domain of EccC (11, 84) and
for full-length EccC in the context of the membrane complex (11, 40, 79).
The fifthmembrane component,mycosin orMycP, is a membrane-bound, subtilisin-like serine
protease that is not part of the coremembrane complex (11, 54, 107) but is highly conserved within
actinobacterial T7SSs (55). Crystal structures of MycP1 and MycP3 show a typical subtilisin-like
α/β structure with seven β sheets surrounded by eight α helices and an active site consisting of an
aspartic acid, histidine, and serine residues (95, 112). While subtilisin-like proteases are usually
produced with an N-terminal extension, called propeptide, that blocks the active site and is de-
grading upon protease maturation, mycosins contain a rather unusual N-terminal extension that
does not block the active site and is not processed (112). Instead, this domain is tightly wrapped
around the protease domain and is most likely involved in protein stability (101, 109). Mycosins
are probably involved in processing of substrates, as MycP1 has been shown to cleave the ESX-1
substrate EspB (72, 107). Intriguingly, while MycP is essential for ESX secretion, its protease ac-
tivity is not (72, 107). This essentiality of MycP is probably owed to its role in the stabilization of
the T7SS core membrane complex through a relatively loose or transient interaction (107, 108).


























































































4.2. Assembly of the Core Complex
All five membrane components have been shown to be essential for secretion in the ESX systems
that have been functionally analyzed so far, i.e., ESX-1 (17, 72, 98), ESX-3 (91), and ESX-5 (8, 14,
54). Additionally, deletions of EccB, EccC, or EccD majorly affect the assembly of the membrane
complex (54), while in the absence of EccE or MycP, the membrane complex becomes unstable
(11, 107). The recent EM structures provide much needed information on the composition and
architecture of the T7SS membrane complex (11, 40, 79) (Figures 2e and 3a) and represent a
milestone in mycobacterial research.
Initial blue native PAGE (polyacrylamide gel electrophoresis) analysis has shown that the four
Ecc components of ESX-1 and ESX-5 from M. marinum and M. bovis form similar full-length
membrane complexes of >1.5 MDa (54, 107). Subsequently, a 13-Å resolution structure of an
ESX-5 system, solved by negative-stain EM, described a large and relatively unstable hexameric
complex (11) (Figure 3a). Based on the size and stoichiometry determination by mass spectrome-
try, it was estimated that the complex is composed of six copies of each component. Although the
use of staining agents limits the overall acquired detail of the protein complex, a large central pore
is visible with a diameter of ∼50 Å, which should be able to accommodate folded heterodimeric
substrates. In addition, six copies of EccB could fit in the center of the periplasmic side of the com-
plex, while immunogold-labeling positioned EccE at the periphery of the membrane complex.
Although visible on the single-particle level as randomly oriented long extensions stemming from
the core structure, EccC is not resolved in the 3D reconstructed image due to its high flexibility
(11).
High-resolution structural information was recently obtained by two groups who analyzed an
intermediate, more stable, dimeric structure of the ESX-3 complex from M. smegmatis (40, 79)
(Figure 2e). Although higher oligomeric states were observed, these were not analyzed in de-
tail (40, 79). The 3.7-Å structures show two protomers, linked through EccB-EccB interactions
mainly through their periplasmic domains, with an EccB/C/D/E stoichiometry of 1:1:2:1. The
difference in stoichiometry is probably due to the hydrophobic nature of EccD, which is prone
to aggregation upon detergent extraction (E.N.G. Houben, C.M. Bunduc, personal observation).
Each EccD monomer forms crucial interactions with either the cytoplasmic domain of the pe-
ripheral protein EccE, or with EccC, explaining why EccD is crucial for complex stability (40,
79). It has been suggested that the observed protomer, with a lipid-containing cavity between
the EccD dimers (Figure 2e), might function as secretion machinery. However, based on mul-
tiple observations of high-molecular-weight oligomeric complexes in mycobacteria (11, 40, 54,
107), but also on the likelihood that EccC functions as a hexamer, similar to other FtsK/SpoIIIE
ATPases (47), the functional T7SS unit most likely is an∼2-MDa hexameric complex (Figure 3b).
Intriguingly, the hexameric complex is relatively unstable upon extraction from the mycobacte-
rial cell envelope, resulting in the appearance of distinctive subcomplexes, all of which contain
the four Ecc membrane components (11, 40, 54). As such, multiple intermediate states are visible
upon membrane extraction, similar to pie slices, where each slice, i.e., the protomer, still contains
all four components. This suggests that, while the single or dimeric protomer is a more stable
unit (11, 40), the hexameric complex requires certain stabilization techniques for its successful
(structural) analysis upon extraction from their native environment (11, 40). A possible explana-
tion for this high instability could be that the MycP protease, which is a stabilizing factor for the
core membrane complex, is not copurified with the membrane complex (107). In addition, lipids
of the inner membrane might be crucial for complex stability (36), as lipids are known to alter
the oligomeric state of membrane proteins (51, 80). What is clear from the structural analysis is
that the dimensions of the complex dictate that it only span the mycobacterial inner membrane.


























































































This means that the mechanism of substrate translocation across the mycobacterial OM remains
unknown (see below).
5. MECHANISM OF SUBSTRATE RECOGNITION AND TRANSPORT
5.1. Substrate Recognition by the EccC ATPase and Mechanism
of Inner Membrane Translocation
Although the mechanism of substrate recognition and transport through the diderm mycobac-
terial cell envelope is still little understood, recent studies have provided crucial insight into the
mode of translocation across the inner membrane.
The EccC ATPase is a key component for substrate export from the cytoplasmic compart-
ment. Biochemical and structural analysis using the soluble domains of EccC1 of M. tuberculosis
and EccC of the actinobacterium Thermomonospora curvata, respectively, have shown that the most
C-terminal seven amino acids of EsxB, C-terminal from the YxxxD motif, bind to a pocket on the
third NBD of EccC (84) (Figure 2c). This interaction should potentially reduce the flexibility of
EccC, thereby triggering themultimerization of the cytoplasmic ATPase domains (84).This bind-
ing event might induce multimerization of the flexible domains of the membrane-bound ATPase,
potentially into a triple-stacked (or quadruple-stacked when including the DUF domain) ATPase
hexamer (11, 84) (Figure 4). EccC multimerization could lead to ATPase activation of the crucial
NBD1 (11, 40, 84). It should be noted that EsxB is able to trigger multimerization of the soluble
domain of EccC only when it is not in complex with EsxA, as this protein has an antagonizing
effect on the EccC-EsxB interaction (84). Considering that EsxB and EsxA form highly stable
heterodimers and are cosecreted, the role of these substrates in EccC multimerization remains
unclear. In addition, as the YxxxD/E secretion motif is not directly involved in binding to EccC,
the role of this conserved motif in substrate recognition remains to be clarified.
An additional question that remains is how the other substrate classes, i.e., the PE, PPE, and
Esp proteins, are recognized by the secretion complex. Interestingly, a specific region in the linker
2 region of EccC5 has been shown to be responsible for the species-specific secretion of the large
ESX-5 substrate subfamily of PE_PGRS proteins (18). This region in the linker 2 domain is miss-
ing in the reported crystal structure of EccC of T. curvata (84) and shows structural variability be-
tween the two protomers of the dimeric membrane complex, suggesting flexibility (79). Although
a direct interaction between this region and the substrates has not been shown, it does indicate
that this domain is involved in the recognition of PE_PGRS substrate, and therefore perhaps also
of other PE and PPE substrates. As EspG is involved in determining the system specificity of
PE/PPE substrates, this chaperone might also play a role in the binding of PE/PPE substrates to
the linker 2 domain. Dissociation of EspG from the substrate pair, potentially mediated by EccA,
most likely occurs before or during the EccC activation step.
Additionally, the crystal structure of the dimeric soluble domain of EccD1 shows a differ-
ent arrangement compared to the two equivalent domains in the ESX-3 membrane protomer
(Figure 2d,e). As such, it seems likely that conformational changes of these two EccD domains
can release or allow movement of EccC, which in turn will lead to rearrangement of the cyto-
plasmic ATPase domains into a secretion-competent state upon substrate binding (see below).
Although it is becoming clear that EccC plays a central role in substrate recognition, the mecha-
nism of substrate transport through the membrane complex remains ill characterized.
5.2. Substrate Codependence for Secretion
While it is obvious that the two partner proteins that form a heterodimer are interdependent
for secretion, this phenomenon of codependence is observed beyond dimeric partners, especially
























































































































































Proposed model for activation of and secretion by mycobacterial T7SSs. (a) Esx, PE/PPE, and Esp substrates form heterodimers with
the conserved YxxxD/E secretion motif in the C terminus of one of the partner proteins (red box). EspG and Esp chaperones keep
PE/PPE and Esp heterodimers, respectively, soluble in the cytoplasm and possibly target them to the secretion machinery in the
mycobacterial cell envelope. The cytosolic domains of EccC in the hexameric membrane complex are highly flexible, while the
secretion pore is closed by the periplasmic domains of the EccB subunits. (b) Binding of Esx substrates on the C-terminal NBD3
reduces EccC flexibility and arranges the ATPase domains into a hexameric assembly, required for the R-finger mechanism of ATPase
activation. (c) Protein export is possibly triggered by the binding of a PE/PPE heterodimer to the linker 2 domain connecting NBD1
and NBD2, activating the crucial NBD1. Concurrently, changes in the conformation of the EccD cytoplasmic domains release or allow
movement of the DUF domain of EccC. These changes in EccC trigger EccB rearrangements through the observed EccC-EccB
interaction, resulting in opening of the membrane channel. (d) In our model, secretion through the OM is mediated by pores created by
specific T7SS substrates. Abbreviations: AG, arabinogalactan; IM, inner membrane; NBD, nucleotide-binding domain; OM, outer
membrane; PG, peptidoglycan; T7SS, type VII secretion system.
for ESX-1 substrates. For instance, secretion of EspC/EspA is dependent on the presence of
EsxB/EsxA and vice versa (42, 64). Similarly, secretion of EspB and secretion of EsxB/EsxA are
also codependent (70). In addition, this substrate interdependence has also been observed for ESX-
5; for instance, the ESX-5 substrate PPE38 has been shown to be required for secretion of the
PE_PGRS and PPE-MPTR protein subfamilies (7).
While the mechanism of substrate interdependence remains unknown, recent data show that
inM.marinum, secretion of an ectopically expressed ESX-1-dependent Esx heterodimer requires
the coexpression of a PE/PPE pair that is encoded by the same operon (32). Intriguingly, rerout-
ing of this PE/PPE pair to another system, by changing the EspG-binding domain on the PPE
protein, results also in the co-redirection of the Esx pair (32). This suggests that the PE/PPE pair
determines the system specificity of the Esx pair and indicates that the binding of Esx substrates
to EccC is not system specific.
The observed codependence of Esx and PE/PPE substrates can be explained by a dual substrate
binding model for EccC (84). In this model, the cytosolic domains of the six EccC subunits of
the membrane complex are flexible in the nonactive state. Upon binding of Esx substrates to the
third NBD, these domains become less flexible and assemble into a staked three-NBD hexamer


























































































(Figure 4). A second binding event to the linker 2 domain by substrates belonging to the PE/PPE
family and/or their interacting chaperones, relieves the inhibitory effect of this linker domain
on NBD1, thereby activating the membrane complex (Figures 2b and 4). This second binding
event primesNBD1 for nucleotide binding and subsequent hydrolysis.Additionally, this step could
trigger conformational changes in EccB through the observed EccB-EccC interactions, allowing
protein transfer through the membrane complex.
5.3. Possible Mechanisms of Outer Membrane Translocation
The size of the T7SS core membrane complex dictates that it is not large enough to span the
complete diderm cell envelope of mycobacteria. As such, translocation over the mycobacterial
OM still remains a mystery.
As all T7SS membrane components are present throughout the Actinobacteria, including those
that lack an OM, it suggests that they do not play a role in transport across this second membrane.
Consequently, translocation over the OM is most likely mediated by additional components. The
observation that no such components are copurified with the core complex (11, 40, 54, 79) sug-
gests that there is no stable interaction between the inner membrane complex and the putative
OM component(s), which hints to secretion as a two-step process. However, a one-step secretion
mechanism cannot be ruled out yet, as putative transient interactions can be lost during the pu-
rification procedure (107) and no periplasmic accumulation of T7S substrates has been identified.
Finding the OM component of T7SSs is complicated by the scarce information available on
mycobacterial OM proteins. MspA and its homologs MspB, MspC, and MspD are essential in
mediating uptake of glycerol and phosphate over the OM in fast-growing species by forming β
barrel–like porins (99). However, these porins are all absent in M. tuberculosis and other slow-
growing species. In M. tuberculosis, CpnT and SpmT, and more recently also specific PE/PPE
proteins, have been found to mediate uptake of nutrients (33, 61, 97, 114). However, structural
information on the membrane-spanning domains of these proteins is still lacking (33, 97). Addi-
tionally, neither of these proteins has been associated with protein transport, making it unlikely
that these are involved in T7SS.
Based on the observed substrate interdependence for secretion, it has been postulated that
specific T7SS substrates might mediate protein transport over the mycobacterial OM, although
there is no hard evidence for this yet. Two indications for this are the observations that two ESX-
1-secreted substrates, EspB and EspC, have the tendency to multimerize into heptameric tubular-
shaped particles and filaments, respectively, structures that were both hypothesized to be able to
penetrate membranes (60, 64, 96). As EspB shows a similar fold as PE/PPE dimers, this suggests
that PE/PPE substrates might also oligomerize upon secretion and that EspG binding is required
to prevent premature multimerization (96). In line with this hypothesis, several PE and PPE pro-
teins have been shown to be firmly associated with the mycobacterial cell envelope (41, 61, 114). A
final support for the role of specific PE/PPE proteins in OM translocation comes fromM. smeg-
matis reconstitution experiments. Introduction of the entire Mycobacterium xenopi esx-5 locus in
M. smegmatis results in a functionally reconstituted ESX-5 system (11). AsM. smegmatis naturally
lacks an ESX-5 system, functional reconstitution, including OM translocation, should probably
be driven entirely by the plasmid-encoded components. As the genes coding for the membrane
components can probably be ruled out, the plasmid-encoded substrates and especially the PPE
proteins are the major candidates. However, how these substrates are inserted into the mycolic
acid–containing layer and how subsequent transport takes place across this layer remain uncer-
tain. Alternatively, the OM translocation step could be achieved by a component already present
in M. smegmatis, which would imply that this protein is able to function as an OM channel for
different ESX systems from different species.


























































































6. CONCLUSIONS AND OUTLOOK
Since the discovery of the ESX-1 secretion system in 2003 (98), substantial progress has beenmade
in the molecular, functional, and structural characterization of T7SSs. Nevertheless, we are only
starting to get real mechanistic insight into substrate recognition by and transport throughT7SSs,
as studies to address this are complicated due to the intricate interplay between various substrates
and the localization of the T7SS membrane complex in the relatively inaccessible mycobacte-
rial cell envelope. A high-resolution structure of the full hexameric membrane complex, together
with its accessory proteins, such as MycP, will undoubtedly help in the further understanding of
the mechanism of transport. Visualization of the complex within the mycobacterial cell envelope
by cryo–electron tomography could also help in addressing how substrates are translocated across
the outer membrane. Finally, more genetic and biochemical work is required to understand the
mechanism of the observed codependence of substrates for secretion.Considering the importance
and diverse roles of T7SSs in the life cycle ofM. tuberculosis, elucidating their mechanism and func-
tions would provide opportunities for understanding the ancient disease it causes and combating
this pathogen.
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